Besides, mitochondrial ROS can control T lymphocyte activation by upregulating IL-2 and IL-4 expression, and using T lymphocytes isolated from patients with atopic dermatitis, the inhibition of Complex I-mediated ROS blocks disease-associated spontaneous hyperexpression and TCR-induced expression of IL-4 (189). Here, IL4 is linked to atopic eczema.